Liaoning Chengda Biotechnology Co. Ltd. Class ASSE: 688739

"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on Expiration of Shareholding Reduction Plan of Senior Executive and Results of Shareholding Reduction

Sep 22, 2026 · Issued by Liaoning Chengda Biotechnology Co. Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 22, 2026

Announcement on Expiration of Shareholding Reduction Plan of Senior Executive and Results of Shareholding Reduction

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Liaoning Chengda Biotechnology Co. Ltd. Class A

"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on Convening the 2026 Semi-annual Performance BriefingSep 15
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Special Report on the Deposit and Actual Use of Raised Funds for the First Half of 2026Aug 25
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Results of the Special Governance Review by the Audit Committee of the Board of DirectorsAug 21
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Initiation of Phase I Clinical Trial for Influenza Vaccine (Split Virion, High-Dose)Jul 18

All Liaoning Chengda Biotechnology Co. Ltd. Class A news releases